DeepMed Research

ONO PHARMACEUTICAL CO

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 1947-01-01

Employees: -

Market Cap: $7.1B

Website: https://www.ono.co.jp/

Clinical Trials

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Phase 2

Not yet recruiting

Conditions: Colorectal Cancer

Interventions: Drug: ONO-4578
Drug: Opdivo®
Drug: Oxaliplatin
Drug: Leucovorin
Drug: 5-Fluorouracil
Drug: Bevacizumab

First Posted Date: 2025-04-29

Last Posted Date: 2025-04-29

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 144

Registration Number: NCT06948448

ONO-4538 Study in Patients With Richter's Transformation

Phase 2

Not yet recruiting

Conditions: Richter's Transformation

Interventions: Drug: ONO-4538

First Posted Date: 2025-04-20

Last Posted Date: 2025-04-20

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 14

Registration Number: NCT06936943

Locations: 🇯🇵
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
🇯🇵
Kyusyu University Hospital, Fukuoka, Japan

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Phase 2

Recruiting

Conditions: Agitation Associated With Alzheimer's Disease Dementia

Interventions: Drug: ONO-2020
Drug: Placebo

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-28

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 90

Registration Number: NCT06803823

Locations: 🇯🇵
Hatano Kousei Hospital, Kanagawa, Japan
🇯🇵
Rainbow & Sea Hospital, Saga, Japan

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Phase 2

Recruiting

Conditions: Alzheimer Disease

Interventions: Drug: ONO-2020
Drug: Placebo

First Posted Date: 2025-03-18

Last Posted Date: 2025-05-02

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 240

Registration Number: NCT06881836

Locations: 🇺🇸
Sandhill Research, LLC d/b/a Accel Research Sites - NeuroStudies CRU, Decatur, Georgia, United States
🇺🇸
ActivMed Research, Methuen, Massachusetts, United States
🇯🇵
Inage Neurology and Memory Clinic, Chiba, Japan

and more 9 locations

A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors

Phase 1

Recruiting

Conditions: NSCLC
Solid Tumor

Interventions: Drug: ONO-7428

First Posted Date: 2025-02-10

Last Posted Date: 2025-04-25

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 60

Registration Number: NCT06816108

Locations: 🇯🇵
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵
Osaka International Cancer Institute, Osaka-shi, Osaka, Japan
🇯🇵
The Cancer Institute Hospital Of JFCR, Koto-Ku, Tokyo, Japan

A Study of ONO-1110 in Patients With Social Anxiety Disorder

Phase 2

Recruiting

Conditions: Social Anxiety Disorder (SAD)

Interventions: Drug: ONO-1110
Drug: Placebo

First Posted Date: 2025-02-03

Last Posted Date: 2025-03-19

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 100

Registration Number: NCT06805565

Locations: 🇯🇵
Kokura Mental Clinic, Fukuoka, Japan

A Study of ONO-1110 in Patients With Major Depressive Disorder

Phase 2

Recruiting

Conditions: Major Depressive Disorder (MDD

Interventions: Drug: ONO-1110
Drug: Placebo

First Posted Date: 2025-01-24

Last Posted Date: 2025-03-18

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 100

Registration Number: NCT06792136

Locations: 🇯🇵
Kokura Mental Clinic, Fukuoka, Japan

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

Phase 2

Recruiting

Conditions: Hunner Type Interstitial Cystitis

Interventions: Drug: ONO-1110
Drug: Placebo

First Posted Date: 2024-12-30

Last Posted Date: 2025-04-04

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 50

Registration Number: NCT06752603

Locations: 🇯🇵
Harasanshin Hospital, Fukuoka, Japan
🇯🇵
Japanese Red Cross Gifu Hospital, Gifu, Japan
🇯🇵
Ueda Clinic, Kyoto, Japan

and more 12 locations

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

Phase 2

Recruiting

Conditions: Fibromyalgia

Interventions: Drug: ONO-1110
Drug: Placebo

First Posted Date: 2024-12-30

Last Posted Date: 2025-02-21

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 160

Registration Number: NCT06752590

Locations: 🇯🇵
Kimura Clinic, Nagoya, Aichi, Japan
🇯🇵
Ginza Neurological Clinic, Tokyo, Japan
🇯🇵
National Hospital Organization Shimoshizu National Hospital, Yotsukaidō, Chiba, Japan

and more 17 locations

Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: a Nationwide Study

Not yet recruiting

Conditions: Primary Central Nervous System Lymphoma (PCNSL)

First Posted Date: 2024-12-03

Last Posted Date: 2024-12-03

Lead Sponsor: Ono Pharmaceutical Co. Ltd

Target Recruit Count: 35

Registration Number: NCT06714370

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy